Prasterone

The companies will jointly control Cosette, with a focus on accelerating innovation and growth. Since Avista's initial investment in Cosette in December 2018, Cosette has launched new products through research and development efforts, acquisitions, and licensing deals. This includes the acquisition of Ambien and Ambien CR in the United States from Sanofi US. The company reports that these initiatives have led to significant EBITDA growth and free cash flow generation, positioning Cosette for future opportunities. Apurva Saraf, president and CEO of Cosette, said: “This partnership is a testament to the remarkable transformation our business has achieved over the past four years, driven by an unwavering commitment to strategic business development and operational excellence. I am immensely proud of the entire Cosette team for their dedication in delivering this robust growth. “We have successfully diversified our portfolio with branded products such as Clomid, Ambien, and Benicar, along with innovative, patent-protected drugs like Vyleesi and Intrarosa. With our strong R&D and business development pipeline, we are well positioned to drive substantial growth in partnership with Avista and Hamilton Lane." Financial strength and future opportunities for Cosette Pharmaceuticals The companies indicate that this transaction will enhance Cosette's balance sheet and support growth through investments in R&D and strategic acquisitions. The goal is to build a durable, high-growth, branded pharmaceutical company. As part of the transaction, Cosette has also secured a new term loan financing with Hayfin Capital Management and a new revolving credit facility provided by UBS Investment Bank, Capital One, National Association, and Santander Corporate & Investment Bank, who acted as joint lead arrangers and joint bookrunners for the financing. googletag.cmd.push(function () { googletag.display('text-ad1'); }); David Burgstahler, managing partner and CEO of Avista, added: “We value Avista's long-term relationship with Hamilton Lane and look forward to collaborating with them as a strategic partner to drive growth and value at Cosette. Our collective expertise will prove invaluable as Cosette evaluates larger M&A opportunities as part of the company's growth strategy.” Cosette Pharmaceuticals has made significant contributions to the pharmaceutical industry, particularly in the realm of specialty pharmaceuticals. The company has a strong focus on developing and commercializing branded and generic products that address unmet medical needs. With a diverse portfolio that includes notable products, Cosette has demonstrated a commitment to innovation and patient care. It says its strategic approach to research and development, coupled with targeted acquisitions and licensing deals, has enabled them to introduce groundbreaking therapies and expand their market presence, positively impacting patient outcomes and advancing healthcare solutions.

SCOTTSDALE, Ariz., April 8, 2024 /PRNewswire/ -- Premium Jane, a household name in the health supplements industry for nearly a decade, has unveiled a line of new products that are designed to complement and accelerate the benefits of a ketogenic diet. The "keto" diet, known for its emphasis on low-carb/high-fat calorie intake, has surged in popularity recently for its ability to help rapidly shed pounds, increase energy levels, and sharpen mental focus and acuity. After years of researching how to optimize this diet, Premium Jane has developed a range of products that are engineered to speed up the results of keto, as well as maintain the effects of the ketogenic state. The cornerstone of Premium Jane's new Keto line is a once-a-day fiber supplement formulated with inulin and chicory root - two crucial (but often overlooked) components of the ketogenic diet. Inulin is a type of soluble plant fiber that bypasses much of the digestive system until it reaches the colon. There, it serves as a prebiotic fiber and nourishes beneficial bacteria (such as Bifidobacteria and Lactobacilli) in the gut. By stimulating the growth of beneficial bacteria, inulin helps maintain a healthy balance of gut microflora. This is essential for balanced digestion, immune function, mental sharpness, and a whole lot more. Another key function of the product is its potential to help slow down emptying of the stomach, thereby enhancing feelings of fullness and boosting weight loss efforts. "We are beyond thrilled to unveil our new Keto product line," says Premium Jane CEO Jeff Yauck. "The ketogenic state isn't just a trend; we, along with research experts across the world, believe it really is the future of health and weight loss." In addition to the inulin fiber supplement, Premium Jane has also released a line of dietary capsules containing 7-keto DHEA - a naturally occurring metabolite of dehydroepiandrosterone (DHEA). 7-keto DHEA has been studied for its potential to enhance metabolic rate and support fat loss, making it an ideal complement to a ketogenic lifestyle. Additionally, Premium Jane is offering Keto BHB gummies, which contain a unique blend of calcium, magnesium, and sodium beta-hydroxybutyrate (BHB). Research is showing BHB to have profound effects on mental clarity, sustained energy, and accelerated fat burning. To place an order or to learn more about the new Keto product range from Premium Jane, visit the company's official website at . Contact: Premium Jane [email protected] SOURCE Premium Jane